DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
58 hedge funds and large institutions have $18M invested in DMK Pharmaceuticals Corporation Common Stock in 2017 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
38% less capital invested
Capital invested by funds: $29M → $18M (-$11M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
58
Holding in Top 10
–
Calls
$504K
Puts
$737K
Top Buyers
| 1 | +$1.02M | |
| 2 | +$466K | |
| 3 | +$465K | |
| 4 |
VF
Virtu Financial
New York
|
+$442K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$435K |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$1.94M | |
| 3 | -$524K | |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$214K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$153K |